Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

EMG of Gait Under Dual-Task in Parkinson Desease

Trial N/A Completed May 12, 2026

Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

Trial Phase 2 Active, not recruiting May 12, 2026

C-STAR Movement Database

Trial N/A Active, not recruiting May 11, 2026

Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson's Disease

Trial N/A Completed May 11, 2026

The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease

Trial N/A Recruiting May 11, 2026

AID-FOG: Artificial Intelligence-Driven Freezing of Gait Detection in the Home

Trial N/A Recruiting May 11, 2026

New Clinical Rehabilitation Approach for the Management of Falls Risks

Trial N/A Completed May 11, 2026

PET Imaging in Parkinson Disease Dementia

Trial N/A Active, not recruiting May 11, 2026

Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF)

Trial N/A Recruiting May 10, 2026

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Trial Phase 2 Recruiting May 10, 2026

Patient-Specific 3D Action Observation Training in Parkinson's Disease

Trial N/A Recruiting May 10, 2026

Prevention of Medical, Social, and Psychosocial Risks Following a Parkinson's Disease Diagnosis: A Pilot Study

Trial N/A Not yet recruiting May 10, 2026

Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

Trial N/A Recruiting May 10, 2026

This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.

Trial Phase 1 Recruiting May 10, 2026

Psilocybin Therapy for Psychological Distress in Palliative Patients

Trial Phase 2 Recruiting May 7, 2026

Aim 3 Particle Swarm Optimization PIGD

Trial N/A Recruiting May 7, 2026

Impact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's Disease

Trial N/A Recruiting May 7, 2026

Investigations of Dementia in Parkinson Disease

Trial N/A Recruiting May 7, 2026

Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)

Trial N/A Completed May 7, 2026

Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease

Trial Phase 2 Recruiting May 7, 2026